Influence of hepatic neoplasia on life expectancy in dogs.
dogs
life span
liver tumor
metastatic tumor
primary tumor
Journal
Veterinary world
ISSN: 0972-8988
Titre abrégé: Vet World
Pays: India
ID NLM: 101504872
Informations de publication
Date de publication:
Mar 2020
Mar 2020
Historique:
received:
03
10
2019
accepted:
16
01
2020
entrez:
6
5
2020
pubmed:
6
5
2020
medline:
6
5
2020
Statut:
ppublish
Résumé
The present study investigated the influence of liver tumor structure on life expectancy in dogs. Diseases of the liver comprise 5-25% of all non-communicable diseases in dogs, and primary hepatic tumors account for 0.6-1.3% of tumors. This research aimed to study the post-operative life span of animals with primary or metastatic tumors of the liver. During the study period, 7124 oncological operations were performed in our clinic. In total, 128 liver tumors were detected in live animals, while 323 were detected posthumously. Forty animals underwent surgery for various liver tumors. In dogs with primary liver tumors, the average age was 11.9 years and the average body weight was 15.5 kg, while in dogs with liver metastases, the mean age was 11.4 years and the average body weight was 24 kg. The ratio of males to females among dogs with primary liver tumors was about 1:1 (ten females and nine males), while that among dogs with metastatic liver damage was clearly predominantly female (14 females and two males) because females often undergo surgery for cancerous mammary glands or ovaries. The size of tumors and the number of affected lobes had a significant effect on the post-operative life span. With a tumor size of <5 cm and a lesion covering less than two lobes of the liver, life expectancy was significantly longer and the prognosis was more favorable. In cases of large tumors or those affecting more than two lobes, life expectancy was significantly reduced and the prognosis was cautious to unfavorable.
Sections du résumé
BACKGROUND AND AIM
OBJECTIVE
The present study investigated the influence of liver tumor structure on life expectancy in dogs. Diseases of the liver comprise 5-25% of all non-communicable diseases in dogs, and primary hepatic tumors account for 0.6-1.3% of tumors. This research aimed to study the post-operative life span of animals with primary or metastatic tumors of the liver.
MATERIALS AND METHODS
METHODS
During the study period, 7124 oncological operations were performed in our clinic. In total, 128 liver tumors were detected in live animals, while 323 were detected posthumously. Forty animals underwent surgery for various liver tumors. In dogs with primary liver tumors, the average age was 11.9 years and the average body weight was 15.5 kg, while in dogs with liver metastases, the mean age was 11.4 years and the average body weight was 24 kg.
RESULTS
RESULTS
The ratio of males to females among dogs with primary liver tumors was about 1:1 (ten females and nine males), while that among dogs with metastatic liver damage was clearly predominantly female (14 females and two males) because females often undergo surgery for cancerous mammary glands or ovaries.
CONCLUSION
CONCLUSIONS
The size of tumors and the number of affected lobes had a significant effect on the post-operative life span. With a tumor size of <5 cm and a lesion covering less than two lobes of the liver, life expectancy was significantly longer and the prognosis was more favorable. In cases of large tumors or those affecting more than two lobes, life expectancy was significantly reduced and the prognosis was cautious to unfavorable.
Identifiants
pubmed: 32367943
doi: 10.14202/vetworld.2020.413-418
pii: Vetworld-13-413
pmc: PMC7183475
doi:
Types de publication
Journal Article
Langues
eng
Pagination
413-418Informations de copyright
Copyright: © Vilkovyskiy, et al.
Références
J Am Vet Med Assoc. 2017 Jan 1;250(1):79-85
pubmed: 28001112
Proc Nutr Soc. 2018 Nov;77(4):394-402
pubmed: 29708079
Vet Comp Oncol. 2016 Jun;14(2):170-80
pubmed: 24428588
Can Vet J. 2015 Jun;56(6):598-604
pubmed: 26028682
Vet Clin North Am Small Anim Pract. 2017 May;47(3):725-735
pubmed: 28063743
Cancer Med. 2016 Sep;5(9):2268-75
pubmed: 27484851
Radiol Oncol. 2017 Jan 14;51(1):40-46
pubmed: 28265231
Top Companion Anim Med. 2019 Jun;35:1-5
pubmed: 31122681
Oncol Lett. 2016 Jun;11(6):3929-3932
pubmed: 27313719
Vet Clin Pathol. 2017 Sep;46(3):520-525
pubmed: 28582596
Clin Res Hepatol Gastroenterol. 2018 Apr;42(2):e23-e28
pubmed: 28645742
Vet Radiol Ultrasound. 2016 Mar-Apr;57(2):144-53
pubmed: 26763951
Vet Radiol Ultrasound. 2017 May;58(3):E26-E30
pubmed: 27377289
Can Vet J. 2013 Sep;54(9):845-8
pubmed: 24155487
Vet Clin North Am Small Anim Pract. 2017 May;47(3):569-583
pubmed: 28081862
Hepatol Res. 2017 Jun;47(7):650-657
pubmed: 27487979
Sci Rep. 2018 Feb 19;8(1):3307
pubmed: 29459629
Vet Surg. 2016 May;45(4):427-35
pubmed: 27007886
Vet World. 2019 Jul;12(7):932-937
pubmed: 31528014
Vet J. 2018 May;235:16-21
pubmed: 29704934
J Hepatocell Carcinoma. 2016 Oct 05;3:41-53
pubmed: 27785449
Surgery. 2018 Apr;163(4):709-713
pubmed: 29273176
Radiology. 2018 Jun;287(3):1050-1058
pubmed: 29688155
J Gastrointest Oncol. 2017 Apr;8(2):337-346
pubmed: 28480072
Lab Anim. 2014 Apr;48(2):132-42
pubmed: 24362593
Int J Hyperthermia. 2018 Nov;34(7):1049-1052
pubmed: 28982246
J Vet Med Sci. 2016 Jan;77(12):1549-53
pubmed: 26118410